No Data
Eddy Pharmaceuticals: Eddy Pharmaceuticals Third Quarter 2024 Report
Eddy Pharmaceuticals 2024 Third Quarter Report
Director and Vice President Wang Jun of Jiangsu Aidea Pharmaceutical (688488.SH) completed the shareholding of 0.6921 million shares.
Jiangsu Aidea Pharmaceutical (688488.SH) announced that the director and vice president Wang Jun has cumulatively reduced his shareholding through centralized bidding...
China Accepts Jiangsu Aidea Pharma's New Indication for HIV Medication
Investor Optimism Abounds Jiangsu Aidea Pharmaceutical Co., Ltd. (SHSE:688488) But Growth Is Lacking
Jiangsu Aidea Pharmaceutical Withdraws Marketing Authorization Application for HIV Tablets
What Jiangsu Aidea Pharmaceutical Co., Ltd.'s (SHSE:688488) 27% Share Price Gain Is Not Telling YouNo Data
No Data
